Prevalence is the actual number of cases alive with the disease, either during a period of time (period prevalence) or at a particular date in time (point prevalence).
Incidence is the rate of new (or newly diagnosed) cases of the disease, generally reported as the number of new cases occurring within a period.
On page 6, line 28 it would be useful for the reader to state that this is new registrations due to diabetes, even though if you refer to table 2.
REVIEWER
AP Kengne South African Medical research Council, South Africa REVIEW RETURNED 03-Jan-2017
GENERAL COMMENTS
Sight and severe sight impairment certifications due to diabetic retinopathy in Wales 2007 Wales -2015 In this manuscript, Dr Rebecca Thomas and coworkers report on time trend in sight impairment (SI) and severe sight impairement (SSI) due to diabetes retinopathy (DR) in Wales during 2007 to 2015. Against a background of increasing prevalence and population of people with diabetes, they found a significant decline in SI and SSI due to DR which in the study context could be ascribed to a number of factors including 1) implementation of systematic annual eye examination in people with diabetes, 2) improvement in diabetes management with time; 3) under-reporting of DR. The study add value to existing body of knowledge in this field, the paper is well and succinctly written, and limitations of the study acknowledged by the investigators. The only suggestion I have for the authors is to consider providing estimates (per 100,000 Introduction • Reference primary research in the first sentence rather than a textbook as evidence that diabetic retinopathy is detectable and treatable.
• The second paragraph should outline the prevalence of SI before moving into methods to monitor incidence and prevalence • Line 38: number 5 should be spelled out.
• The knowledge gap being addressed in the paper could be more clearly stated. The introduction tells us it is not the leading cause anymore, what else do we need to know? Why is a more in-depth analysis necessary?
• Is this the only source of data on SI in Wales or is there a register attached to the national screening programme? Providing this information may help to address the previous point. The introduction would be strengthened by providing more detail on the certification process -how is the certification register populated, by whom, is it mandatory for all people with diabetes?
• What year was universal annual DR screening introduced (line 50)
Methods
• The information on the phased introduction of screening in Wales does not seem relevant given that the data analysed correspond to after the introduction of universal screening. This section could be shortened to the last 2 sentences. The timing of the introduction of universal screening should be mentioned in the introduction.
• The first sentence in the section on the numerator is confusing and needs to be rephrased. Presumably, all data analysed were for Wales only not just the numerator. This point should be separated from the information on what data were included for SI and SSI. The coding of each group (any vs diabetic eye disease) should be described separately. At present it reads as if everyone was coded into the same group (any cause and diabetic eye disease = everyone).
• Did the authors define SI based on the Snellen Chart using raw data or is this carried out at initial certification stage?
• Denominator section: Details on the years of data are only given for the population estimates. Were the data for the number of new certifications gathered for each year? Which year"s data were used for the number of people with diabetes?
• Statistical analysis: o This section could be made clearer by explicitly stating the numerator and denominator for each estimate.
o Suggest the first sentence should be more explicit -"The prevalence of new certifications ….were calculated using the (total) number of (new) certifications and the population estimates"
Results
• It is not always clear when data refer to SI and SSI combined. In the opening sentence of this section, the reduction in new certifications for SI and SSI from any cause refer to the two conditions combined however, combined estimates are not mentioned explicitly until the 2nd paragraph. Similarly in paragraph 3, are these estimates for SI and SSI combined?
• What is the percentage reduction in new certifications (due to any cause) over the 7 year period? The % increase in the proportion of certifications dues to DR is mentioned in paragraph 3.
• In paragraph two, it would be clearer to deal with each group separately (combined, SSI and SI).
• Line 43: typo -"of" mentioned twice • The results reported in paragraph 3 on the fluctuation over time could be illustrated in a graph.
Discussion
• In paragraph 1, reporting the raw numbers for the reduction in new certifications does not give the reader any context for interpretation. It may be better to report the % reduction or per population estimates.
• Paragraph 2 -Is the limited number of reports on numbers of certifications due to other more robust data sources being available in other countries? Are other sources available in Wales (e.g. retinopathy register attached to screening) and if so how do the estimates compare?
• Line 27-"In our study the proportion (of new certifications) due to SI and SSI during 2009-2010 was 3.9%"
• The discussion on the number of possible explanations for the reduction in the number of new certifications of SI and SSI due to DR is difficult to follow (paragraph 3). o The rationale for mentioning the relatively few studies that note a reduction in the prevalence of sight threatening retinopathy is unclear. This present study noted a reduction in serious sight impairment. Furthermore, was the WDRS a follow-up of the WESDR or are they separate cohorts? The reference to a "25% reduction to 18%" suggests one is a follow-up of the other, but the description of WDRS refers to a different cohort. We very much appreciate the importance of these comments. Therefore, in the revised manuscript we have acknowledged the fact that during the period of the study the impressive reduction in vision impairment due to diabetes may in part be a consequence of the parallel increase in the population of persons with diabetes. With respect to the Quality and Outcomes Framework from where we derived the numbers of persons know to have diabetes in Wales this process has been in place for a number of years and is a formal requirement by the health authority for primary care to provide this information on an annual basis. We also acknowledge that a fall in the rates of SI and SSI did not occur from the first year of observation. This has been made clear in the revised text. As the reviewer mentioned it is unfortunate that earlier rates prior to 2007 were not available. However, on-going review over the coming years may help to confirm or refute the meaningfulness of the current findings, which is mentioned in the revised manuscript.
Comment: In addition to these major concerns, there are some confusing elements in the text. Incidence figures are sometimes stated without clearly defining the period of time involved (one year? an interval of several years?) ResponseThe results section has now been altered so that all figures stated have clearly for incidence rates the defined periods of time whether this is over one year or a change over several years Comment: On pg. 4, line 54 through pg. 5, line 10, the authors state definitions of "sight impairment (SI)" and "severe sight impairment (SSI)" from "previous studies," that include Snellen visual acuity, but also visual field defects, which are categorized as "moderately" or "severely" constricted. These terms, however, are highly subjective. Can the authors give us definitions based on numerical degrees of constriction? ResponseThe guidelines on certification of sight impairment and severe sight impairment in Wales are issued by the Welsh Government and the Royal College of Ophthalmologists. We have expanded on the definitions of sight impairment and severe sight impairment in the revised manuscript. However, the guidelines do not state numerical degrees of constriction required for certification. (Welsh Government, Certification of Vision Impairment Wales, CVI-W, 2016). The document states: ' To be certified as SSI (blind), sight assessed using the Snellen Chart, while wearing any glasses or contact lenses, will fall into the following categories: visual acuity (V/A) of less than 3/60 with a full visual field, or V/A between than 3/60 and 6/60 with a severe reduction of field of vision, such as tunnel vision, or V/A of 6/60 or above but with a very reduced field of vision, especially if a lot of sight is missing in the lower part of the field. A definition of SI (partial sighted) requires the sight to fall into one of the following categories, while wearing any glasses or contact lenses, a V/A of 3/60 to 6/60 with a full field of vision, or V/A of up to 6/24 with a moderate reduction of field of vision or with a central part of vision that is cloudy or blurry, or V/A of 6/18 or even better if a large part of the field of vision, a whole half of the vision, is missing or a lot of the peripheral vision is missing.'
The methods section has been altered to include the above statements. Prevalence is the actual number of cases alive with the disease, either during a period of time (period prevalence) or at a particular date in time (point prevalence).
ResponseThank you for pointing out this unfortunate error. The paper has now been altered so that the new text clearly states incidence of sight and severe sight impairment and not prevalence. Against a background of increasing prevalence and population of people with diabetes, they found a significant decline in SI and SSI due to DR which in the study context could be ascribed to a number of factors including 1) implementation of systematic annual eye examination in people with diabetes, 2) improvement in diabetes management with time; 3) under-reporting of DR. The study add value to existing body of knowledge in this field, the paper is well and succinctly written, and limitations of the study acknowledged by the investigators.
The only suggestion I have for the authors is to consider providing estimates (per 100,000 population) as well as percent changes with the accompanying 95% confidence intervals, as these will facilitate the interpretation of significant findings. ResponseThank you for these helpful suggestions. In the results section we have now included percent reduction in the incidence of certification.
Comment: Furthermore, the authors should indicate if the relevant ethics approval and administrative authorisation were obtained for this study; and if not obtained, they must explain why.
ResponseThere is now a statement in the methods section and at the end of the revised manuscript stating 'All patients provide explicit consent for certification and for anonymised data to be transferred to the Certifications Office. As all data analysed in this study was anonymised and therefore no ethical approval was required.' …………………………………………………………………………………………………………… Reviewer: 4 Reviewer Name: Sheena McHugh Institution and Country: University College Cork, Ireland
Comments: This is an interesting paper that adopts a similar approach to that taken in Ireland to study visual impairment due to diabetic retinopathy. I think the paper needs more context in terms of the certification process, how it works, whether it is the only source of data on the prevalence of sight impairment due to DR etc. The paper also needs to be read carefully as there are a number of typos. Response:
We thank the reviewer for the very detailed comments and suggestions made and hope that we have addressed the many issues relating to the process of certification etc. We have also ensured that there are no typographical errors remaining in the revised manuscript.
I suggest the following changes:
General comments • Diabetic retinopathy/maculopathy is mentioned in the abstract but maculopathy is not mentioned again until discussions about prevalence in the Introduction. There is a reference to "diabetic eye disease (retinopathy/maculopathy)" in the methods (line 18). The terms are used interchangeably through the paper. Is the paper about both or just diabetic retinopathy? For a general non-diabetes specific journal, it should not be presumed that every reader will understand the connection between the two. ResponseWe apologies for the confusion. We have used the term diabetic retinopathy to encompass diabetic retinopathy and maculopathy
Comment:
The terms "new registration", "certification" and "new certification" are also used interchangeably.
ResponseWe agree that the different terms in the original manuscript was confusing. Therefore, the revised manuscript now only uses the term 'new certifications'. The term registration has been eliminated.
Comments Re Abstract: Comment 1
The first reference to severe sight impairment in the first sentence of the abstract should include (SSI) ResponseThe acronym has been added to the abstract. Comment 5 Is this the only source of data on SI in Wales or is there a register attached to the national screening programme? Providing this information may help to address the previous point. The introduction would be strengthened by providing more detail on the certification process -how is the certification register populated, by whom, is it mandatory for all people with diabetes?
ResponseThere is no additional independent register for SI and SSI attached to the national diabetic retinopathy screening programme in Wales and therefore the certification data (CVI-W) utilised in this analysis is the only source of certification for Wales. We have now included a detailed statement about the certification process in the revised manuscript and highlighted the many limitations of the current process. Certification for SI and SSI is presently not mandatory for anyone who meets the criteria and certification needs to be completed by a consultant ophthalmologist and the CVI is then sent to the Certifications Office in Moorfields Eye Hospital.
Comment 6: What year was universal annual DR screening introduced (line 50) ResponseWe hope this has now been answered in the introduction as stated above in response to comment 4 ……………………………………………………………………………………………………………Commen ts Re Methods Comment 1: The information on the phased introduction of screening in Wales does not seem relevant given that the data analysed correspond to after the introduction of universal screening. This section could be shortened to the last 2 sentences. The timing of the introduction of universal screening should be mentioned in the introduction.
ResponseWe appreciate this comment and therefore this section has been altered limiting the history of the DESW and which has been moved to the introduction section.
Comment 2:
The first sentence in the section on the numerator is confusing and needs to be rephrased. Presumably, all data analysed were for Wales only not just the numerator. This point should be separated from the information on what data were included for SI and SSI. The coding of each group (any vs diabetic eye disease) should be described separately. At present it reads as if everyone was coded into the same group (any cause and diabetic eye disease = everyone).
ResponseAs suggested by the reviewer the numerator section has been rephrased to 'The number of new certifications of SI and SSI due to diabetic eye disease (retinopathy/maculopathy) included those cases where the main cause of certifiable SI or SSI was diabetic retinopathy/maculopathy and those where the main cause was recorded as multiple conditions but a contributory cause was diabetic eye disease' ResponseThe statistical analysis section has been altered as followed: ' The incidence of visual impairment (SI and SSI) due to any cause in Wales were calculated using the total number of new certifications and the population estimates for each one year time period between 2007 and 2015. In addition, the incidence of SI and SSI related to DR were calculated using the QoF estimates of people with known diabetes in Wales. The results are represented as the combined total (SI plus SSI), SI and SSI individually when due to either any cause or DR in the population of Wales. The percentage change in the incidence of new certifications for SI and SSI due to any cause or DR during each of the eight annual observation periods were also calculated.'
Comment 6: Suggest the first sentence should be more explicit -"The prevalence of new certifications …. were calculated using the (total) number of (new) certifications and the population estimates" ResponseThis sentence has now been altered in an attempt to make it clearer 'The incidence of visual impairment (SI and SSI) due to any cause in Wales were calculated using the total number of new certifications and the population estimates for each yearly time period between 2007 and 2015.'
Comments Re Results Comment 1: It is not always clear when data refer to SI and SSI combined. In the opening sentence of this section, the reduction in new certifications for SI and SSI from any cause refer to the two conditions combined however, combined estimates are not mentioned explicitly until the 2nd paragraph. Similarly, in paragraph 3, are these estimates for SI and SSI combined? ResponseTaking these comments on board the results section has now been altered with 'combined' or 'individual' added to clarify when using combined SI and SSI numbers of individual figures.
What is the percentage reduction in new certifications (due to any cause) over the 7-year period? The % increase in the proportion of certifications dues to DR is mentioned in paragraph 3. ResponseThe percentage decrease in new certification due to any cause for combined SI and SSI was 21.4%. This has been added into the first paragraph of the results section ' Between 2007 ' Between -2008 ' Between and 2014 ' Between -2015 in Wales there was an overall reduction of 339 in new certifications for SI and SSI combined from any cause i.e. from 1582 to 1243, equivalent to 12.2 per 100,000 of the population representing a decrease of 21.4% over the 8-year observation period (Table 1) (Table 2) . Similarly, there was a temporary increase in both SI and SII during the second annual period of observation with SI certifications thereafter falling consistently from 89 to 51 during 2014-2015 a reduction of 42.7% and SSI falling from 51 to 29 certificates being a fall of 43.1% over the remaining seven years of the study. The overall reduction in SI and SSI combined, SI and SSI for the entire study period from 2007-2008 to 2014-2015 was 20.3%, 20.3% and 29.3% respectively. For the population of Wales the initial rate of new certifications in 2007-2008 for SI and SSI combined, SI and SSI was 3.6, 2.1 and 1.4 per 100,000 respectively followed by slight increase in the second year to 4.6, 2.9 and 1.7 per 100,000 respectively and then a general trend downwards to the lowest rate of 2.8, 1.6 and 0.9 per 100,000 seen respectively' The discussion on the number of possible explanations for the reduction in the number of new certifications of SI and SSI due to DR is difficult to follow (paragraph 3). ResponseWe apologise. This section has now been amended so that it is easier to read ' In our study, there are a number of possible explanations as to why the number of new certifications of SI and SSI due to DR fell during the eight-year period of observation between 2007-2008 and 2014-2015 . Screening for DR was introduced in the Wales in 2003 (23, 24) , along with the parallel availability of new treatments for management of both diabetes and sight-threatening DR and maculopathy (25) (26) (27) (28) (29) . In addition, an increase in the population with diabetes during this period will also contribute to this observation due to the greater awareness of diabetes and changes in diagnostic criteria.'
Comment 5: The rationale for mentioning the relatively few studies that note a reduction in the prevalence of sight threatening retinopathy is unclear. This present study noted a reduction in serious sight impairment. Furthermore, was the WDRS a follow-up of the WESDR or are they separate cohorts? The reference to a "25% reduction to 18%" suggests one is a follow-up of the other, but the description of WDRS refers to a different cohort.
ResponseThis section has been altered to avoid confusion 'To date, relatively few studies have reported a reduction in the prevalence of sight-threatening DR mainly referring to persons with type 1 diabetes (29-31) again suggesting the possible benefit or recent changes in the management of diabetes. In addition a systematic review of 28 studies noted that participants involved from 1986 onwards had a lower proportion of proliferative DR and severe vision loss at 2.6% and 3.2% respectively compared to 1985 and before at 19.5% and 9.7% respectively (30). In our experience in Wales the number of people referred by the DESW to the hospital eye services with sight-threatening DR for ophthalmological review fell from 3.4% in 2007 to 2.0% in 2015. There has also been a decrease in the coverage of certifications especially of partially sighted people and also inappropriate certification due to a variety of reasons (32, 33) . It would be difficult to say if one or any of these changes were primarily responsible for the observed decrease as it is more likely to be a combination of these elements.' ResponseThank you for these remarks based upon which the discussion section has now been altered. The suggestion as to why there is a reduction in sight-threatening diabetic retinopathy is put down as possibly due to improved diabetes care and ophthalmological care (Klein et al 2008) (31). Again, with respect to the findings in this study this may also be the case but in addition there is the added influence of the implementation of the diabetic retinopathy screening service which has resulted in earlier referral of those with sight-threatening diabetic retinopathy and the awareness of primary care to the presence of diabetic retinopathy and the need for improving diabetes management Therefore the discussion has been altered to reflect this as follows: "In addition a systematic review of 28 studies noted that participants involved from 1986 onwards had a lower proportion of proliferative DR and severe vision loss at 2.6% and 3.2% respectively compared to 1985 and before at 19.5% and 9.7% respectively (30). These studies suggest that the reduction in sight-threatening DR is possibly due to improved diabetes and ophthalmological care." "There has also been a decrease in the coverage of certifications especially of partially sighted people and also inappropriate certification due to a variety of reasons (32, 33). Therefore, some of the reduction in sight-threatening DR may in addition to improved care (diabetes and ophthalmological) be due to the influence of the implementation of the National DR screening service which has resulted in earlier referral and increased awareness in Primary Care of the presence of DR and the need for improving diabetes management. It would be difficult to say if one or any of these changes were primarily responsible for the observed decrease as it is more likely to be a combination of these elements."
It is correct that certification for SI and SSI is optional for all people who meet the criteria including those with diabetes and therefore patients can refuse to be certified. Also, disturbingly a study by Barry and Murray Br J Ophthalmol 2005; 89:995-998 (33) found that 23% of those certified as SI or SSI were inappropriate certifications as they were not in accordance with their level of visual impairment. We analysed Certification (CVI-W) as this is the only source of data on SI and SSI in Wales. This data is not routinely collected by the screening programme as people with diabetes who are SI or SSI and under ophthalmologists attending Hospital Eye Services are excluded from the normal diabetic retinopathy screening service.
Comment 7:
The authors refer to the need to improve attendance at eye screening -are rates low in Wales? Is there evidence of a problem with uptake? Responseuptake is 80% [across Wales] so not particularly low but it is recognised that those who do not attend are likely to be most at risk of sight-threatening DR. Studies are currently underway to explore this very important question and to ensure a better uptake into the screening services in order to accommodate this vulnerable segment of the population of people with diabetes.
This section has now been altered as follows: "Studies have also indicated that those persons most at risk of losing vision due to DR either do not attend for eye screening and/or are not fully engaged with the management of their diabetes (36) (37) (38) (39) (40) . In order to ensure the reduced risk for sight loss due to DR in Wales continues, more needs to be done to improve attendance rates for eye screening above its current and stable level at approximately 80%. Studies are currently underway to explore this very important question and to ensure a better uptake into the screening services in order to accommodate this vulnerable segment of the population of people with diabetes. Increased access to structured diabetes education program is another essential way to help those with diabetes to better understand the importance of regular DR screening and the need to achieve and maintain good glycaemic, blood pressure and lipid control.
In conclusion, findings from this analysis provide positive and useful information to assist in the future monitoring of diabetic eye disease in persons in order to provide the basis for assessing the benefit or otherwise of changes in the management of diabetes and diabetic retinopathy/maculopathy. However, improvements are needed to the certification process to enhance its" value by providing reliable and meaningful epidemiological information in support of the eventual aim of eradicating preventable vision threatening eye disease in the ever increasing population of people with diabetes and the general population alike." 
GENERAL COMMENTS
The revised manuscript is clearly improved. Please find my comments below:
